Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Post by Just1Questionon Oct 03, 2023 1:59pm
206 Views
Post# 35667361

Moving Forward

Moving Forwardwith the Strathcona merger and calculating to the best of my ability, I expect I will receive Strathcona shares with an estimated opening market value of $28.32 per share on Thursday representing roughtly a 14.7 to 1 Reverse split ratio while using $1.92 for PIPE as an estimated closing value on October 3rd.. 

A positive is the stock will now be marginable. 

A negative is that In order to recover to my PIPE investment as of January 2023 the Strathcona stock will need to rise to $44.73

The plan - I bought a "few more shares" today to average down, and I'm hoping that by Christmas this will look like a good idea.

Cheers
<< Previous
Bullboard Posts
Next >>